Skip to main content
Clinical Trials/NCT06676137
NCT06676137RecruitingNot Applicable

China Coronary Microvascular Disease(CCMD) Registry

Henan Institute of Cardiovascular Epidemiology1 site in 1 country500 target enrollmentStarted: November 11, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
500
Locations
1
Primary Endpoint
Establish a Registry of CMD patients in China

Study Overview

Brief Summary

Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Angina symptoms
  • Objective evidence of myocardial ischemia
  • Coronary angiography was normal,irregular tube wall, or stenosis <50%

Exclusion Criteria

  • People under the age of 18
  • Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease

Outcomes

Primary Outcomes

Establish a Registry of CMD patients in China

Time Frame: 5 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Henan Institute of Cardiovascular Epidemiology
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials